AR084815A1 - Compuestos analgesicos, metodos y formulaciones - Google Patents

Compuestos analgesicos, metodos y formulaciones

Info

Publication number
AR084815A1
AR084815A1 ARP120100071A ARP120100071A AR084815A1 AR 084815 A1 AR084815 A1 AR 084815A1 AR P120100071 A ARP120100071 A AR P120100071A AR P120100071 A ARP120100071 A AR P120100071A AR 084815 A1 AR084815 A1 AR 084815A1
Authority
AR
Argentina
Prior art keywords
alkyl
hydrogen
phenyl
methods
formulations
Prior art date
Application number
ARP120100071A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR084815A1 publication Critical patent/AR084815A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/20All rings being cycloaliphatic the ring system containing seven carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/50Spiro compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a compuestos, y sales de los mismos de fórmula (1) en donde A es un compuesto de fórmula (2); R1 es hidrógeno, alquilo C1-5, alcoxi C1-5, haloalquilo C1-5, alcanol C1-5, -(alquil C1-5)fenilo, o fenilo, o un grupo de la fórmula -C(O)-R12, donde R12 puede ser alquilo C1-5, alcoxi C1-5, haloalquilo C1-5, alcanol C1-5, -(alquil C1-5)fenilo, o fenilo; R2 y R3 son independientemente hidrógeno, alquilo C1-5, alcoxi C1-5, halógeno, haloalquilo C1-5, o haloalcoxi C1-5; R4 y R5 son independientemente hidrógeno, alquilo C1-5, o -(alquil C1-5)fenilo; R6 es hidrógeno, hidroxi, o está ausente; R7 es hidrógeno; R8 y R9 son independientemente hidrógeno o metilo; R10 es hidrógeno; R11 es hidrógeno o alquilo C1-5; o R7 y R10 se combinan para formar -CH2- o -(CH2)2-; o R8 y R9 se combinan para formar un grupo ciclopropilo con el carbono al cual están unidos; o R10 y R11 se combinan para formar -CH2- o -(CH2)3-. Adicionalmente, se proporcionan formulaciones farmacéuticas y métodos de uso que emplean los compuestos anteriores.
ARP120100071A 2011-01-27 2012-01-10 Compuestos analgesicos, metodos y formulaciones AR084815A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2011/070706 WO2012100423A1 (en) 2011-01-27 2011-01-27 Analgesic compounds, methods, and formulations

Publications (1)

Publication Number Publication Date
AR084815A1 true AR084815A1 (es) 2013-06-26

Family

ID=45558412

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP120100071A AR084815A1 (es) 2011-01-27 2012-01-10 Compuestos analgesicos, metodos y formulaciones
ARP220101618A AR126189A2 (es) 2011-01-27 2022-06-21 Compuestos analgésicos, métodos y formulaciones

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP220101618A AR126189A2 (es) 2011-01-27 2022-06-21 Compuestos analgésicos, métodos y formulaciones

Country Status (22)

Country Link
US (1) US8802728B2 (es)
EP (1) EP2668152B1 (es)
JP (1) JP6002153B2 (es)
KR (1) KR101612168B1 (es)
CN (2) CN103328433B (es)
AR (2) AR084815A1 (es)
AU (1) AU2012209430B2 (es)
BR (1) BR112013018527B1 (es)
CA (1) CA2825816C (es)
CL (1) CL2013002102A1 (es)
CO (1) CO6781505A2 (es)
EA (1) EA024101B1 (es)
ES (1) ES2612495T3 (es)
IL (1) IL227250A (es)
IN (1) IN2013MN01164A (es)
MX (1) MX345518B (es)
MY (1) MY163262A (es)
SG (1) SG192131A1 (es)
TW (1) TWI564275B (es)
UA (1) UA110122C2 (es)
WO (2) WO2012100423A1 (es)
ZA (1) ZA201304786B (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
DE1518663A1 (de) 1965-08-02 1969-12-18 Gruenenthal Chemie Basisch substituierte Cycloalken-derivate und Verfahren zu ihrer Herstellung
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19547766A1 (de) * 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE10049481A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte C-Cyclohexylmethylamin-Derivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
AU2002364517A1 (en) 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof
US20050182131A1 (en) 2002-07-19 2005-08-18 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence
DE10233048A1 (de) * 2002-07-19 2004-01-29 Grünenthal GmbH Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
EP2022778A1 (en) 2007-08-07 2009-02-11 Laboratorios del Dr. Esteve S.A. A crystalline form of (R,R)-tramadol-(S)-naproxene salt

Also Published As

Publication number Publication date
EA201390857A1 (ru) 2014-01-30
EP2668152A2 (en) 2013-12-04
CN105753723B (zh) 2018-11-06
WO2012102875A3 (en) 2012-10-18
MY163262A (en) 2017-08-30
CN103328433B (zh) 2016-06-08
WO2012102875A2 (en) 2012-08-02
TW201242930A (en) 2012-11-01
IN2013MN01164A (es) 2015-04-17
MX2013008708A (es) 2014-01-23
NZ612731A (en) 2015-04-24
SG192131A1 (en) 2013-08-30
CA2825816A1 (en) 2012-08-02
IL227250A (en) 2015-03-31
AU2012209430A1 (en) 2013-07-04
WO2012100423A1 (en) 2012-08-02
MX345518B (es) 2017-02-02
KR20130116348A (ko) 2013-10-23
JP2014511368A (ja) 2014-05-15
CA2825816C (en) 2016-08-09
ES2612495T3 (es) 2017-05-17
ZA201304786B (en) 2014-12-23
BR112013018527B1 (pt) 2021-11-09
US8802728B2 (en) 2014-08-12
CL2013002102A1 (es) 2014-06-27
BR112013018527A2 (pt) 2016-10-18
UA110122C2 (uk) 2015-11-25
KR101612168B1 (ko) 2016-04-12
EA024101B1 (ru) 2016-08-31
CO6781505A2 (es) 2013-10-31
AR126189A2 (es) 2023-09-27
CN105753723A (zh) 2016-07-13
EP2668152B1 (en) 2016-10-12
US20130225679A1 (en) 2013-08-29
JP6002153B2 (ja) 2016-10-05
TWI564275B (zh) 2017-01-01
AU2012209430B2 (en) 2014-11-13
CN103328433A (zh) 2013-09-25

Similar Documents

Publication Publication Date Title
RS54175B1 (en) BROMODOMEN INHIBITORS AND THEIR APPLICATION
AR088668A1 (es) Moleculas pequeñas que contienen boro
RS53395B (en) DERIVATIVES N1-SULFONIL-5-FLUORPIRIMIDINONA
CO6210729A2 (es) Derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona procedimientos para su preparacion y su uso como agente farmaceutico
PE20130375A1 (es) Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos
AR067058A1 (es) Oxazolidinonas sustituidas y su uso para preparar medicamentos
AR082562A1 (es) Derivados de isoxazolina como agentes antiparasitarios
CL2012000999A1 (es) Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina.
AR094262A1 (es) Compuestos antivirales para el tratamiento de la hepatitis c
AR077292A1 (es) Derivados de piperazin - quinolin sulfonamidas y composiciones farmaceuticas
AR087288A1 (es) Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a
AR097431A1 (es) Compuestos de carboxamida de furo y tienopiridina útiles como inhibidores de quinasas pim
ECSP12012293A (es) Ciertas amino-pirimidinas, composicioines de las mismas y métodos para el uso de los mismos
AR067759A1 (es) Compuestos de pirazol utiles como moduladores de la enzima raf asociada al crecimiento celular anormal
AR087549A1 (es) Derivados de 5-fluor-4-imino-3-(sustituido)-3,4-dihidropirimidin-2(1h)ona
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
EA201170118A1 (ru) Циклопропильные ингибиторы полимеразы
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
AR079662A1 (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa
AR092971A1 (es) Inhibidores de agrecanasa
AR072803A1 (es) Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes
AR073043A1 (es) Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras.
AR065157A1 (es) Compuestos de 6-bencil- 2,3,4,7-tetrahidro-indolo [2,3-c] quinolina
MX2013015436A (es) Compuestos de eter amido-piridilico y composiciones y su uso contra parasitos.
AR075951A1 (es) Dihidropiridin sulfonamidas y dihidropiridin sulfamidas como inhibidores de mek

Legal Events

Date Code Title Description
FG Grant, registration